AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
SATRALIZUMAB in Ghana
1 product registered with FDA Ghana — 0 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ENSPRYNG 120MG/ML | UNKNOWN-f62fe4b2 | — | expired | 1 Jun 2026 |
SATRALIZUMAB — FDA Ghana Registration Details
FDA Ghana (Ghana) has 1 registered product containing SATRALIZUMAB, of which 0 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track SATRALIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.